Introduction

Multimodal enhanced recovery programs are a new paradigm in perioperative care.

Objective

To evaluate the certainty of evidence pertaining to the effectiveness and safety of the multimodal perioperative care program in elective colorectal surgery.

Data source: A search was conducted in the Medline, EMBASE, and Cochrane databases, up until February 2020.

Eligibility criteria

Systematic reviews that take into account the perioperative multimodal program in patients with an indication for colorectal surgery were included. The primary outcomes were morbidity and postoperative deaths. The secondary outcome was hospital length of stay.

Study quality and synthesis method

The reviews were evaluated with AMSTAR-2 and the certainty of the evidence with the GRADE methodology. The findings are presented with measures of frequency, risk estimators, or differences.

Results

Six systematic reviews of clinical trials with medium and high quality in AMSTAR-2 were included. Morbidity was reduced between 16 and 48%. Studies are inconclusive regarding postoperative mortality. Hospital length of stay was reduced by an average of 2.5 days (p <0.05). The certainty of the body of evidence is very low.

Limitations

The effect of the program, depending on the combination of elements, is not clear.

Conclusions and implications

Despite the proven evidence that the program is effective in reducing global postoperative morbidity and hospital stay, the body of evidence is of very low quality. Consequently, results may change with new evidence and further research is required.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )